Anokion's Corporate Minority Round

Anokion raised a round of funding on January 10, 2017. Investors include Celgene.

Anokion, a spin-off from the Ecole Polytechnique Federale de Lausanne (EPFL), is focused on applying the company's antigen-specific immune tolerance technology to treat autoimmune and allergic disease…

Articles about Anokion's Corporate Minority Round: